原发性肝癌(PHC)是我国尤其是南方常见的恶性肿瘤之一,恶性程度高,危害大,就诊时多数已属中晚期,及早诊断尤为重要[1]。甲胎蛋白(AFP)用于诊断PHC的价值已得到肯定,但仍有20%~40%的PHC患者AFP阴性或水平较低[2]。本研究的目的是通过检测原发性肝癌患者血清MIC-1含量,探索其用于原发性肝癌诊断的临床价值。对象与方法1对象116例PHC患者为唐山市人民医院肿瘤医院 Primary hepatocellular carcinoma (PHC) is one of the most common malignant tumors in our country, especially in the south of China. It has a high degree of malignancy and is very harmful. Most of the cases are already in advanced stages of treatment. Early diagnosis is particularly important [1]. The value of AFP for the diagnosis of PHC has been affirmed, but 20% to 40% of PHC patients have AFP negative or low levels [2]. The purpose of this study is to detect the clinical value of serum MIC-1 in patients with primary liver cancer for the diagnosis of primary liver cancer. Subjects and methods 1 object 116 cases of PHC patients Tangshan People’s Hospital Tumor Hospital